MustGrow Biologics Sees Positive Soil Health Results In Study

MustGrow Biologics (CSE: MGRO) has seen positive results from a third party confirmatory study related to the active ingredient in its mustard-based technology. The ingredient, Allyl Isothiocyanat, or AITC, has been found to positively impact soil health, confirming that natural AITC provides a healthy alternative to the use of synthetic chemicals.

The application of AITC has been found to return organic plant material to the soil as a part of the pre-plant treatment process. The ingredient also dissipates from the soil quickly, which prevents long-term toxicity to micro-organisms, enabling health soil to continue to thrive.

Fumigation through the use of AITC, while proven effective at controlling soil-borne diseases, has been shown via the study to improve diversity and structure optimization of soil fungal communities, with a large number of beneficial bacteria found to have been present as well. Fumigation has been proven to temporarily reduce diversity of the soil bacteria as it works to kill harmful diseases, while post-fumigation it has been found to have increased fungi related to plant disease control.

Comparatively, synthetic chemicals used in fumigation have been shown to have broad biocidal activity, which is harmful not only to diseases but also to beneficial bacteria, micro-organisms and fungi. As a result synthetic agents have been found to negatively impact soil health.

“The active ingredient, AITC, in MustGrow’s mustard plant-based technology is perfect for use in modern, more sustainable pest control strategies – a biopesticide that is effective, dissipates quickly, leaves no harmful residues, and once gone, improves the soil ecosystem.”

Dr Matthew J Morra, Scientific Advisor to MustGrow

MustGrow Biologics last traded at $2.05 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Isn’t In A Bubble, Currency Is. – Doug Casey

The Real Move Begins When They Cut Rates | Peter Krauth

Is Altamira Gold Sitting On Brazil’s Next Big Gold Discovery?

Recommended

Stifel Initiates Coverage On Goliath Resources With $5.00 Price Target

ESGold Completes Mill Building Construction, Final Equipment Procurement Underway

Related News

MustGrow Biologics Isolates Third Molecule From Mustard Plant

MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different...

Wednesday, March 3, 2021, 08:46:13 AM

MustGrow Biologics Enters Exclusive Arrangement With Bayer

MustGrow Biologics (CSE: MGRO) has entered arrangements with another big name in the life sciences...

Friday, January 21, 2022, 08:34:22 AM

MustGrow Posts Positive Field Trials Results – The Daily Dive

To start off this week’s Daily Dive, we see the return of Colin Bletsky, COO...

Monday, November 15, 2021, 01:30:00 PM

MustGrow Begins Testing Formulation Against Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has begun testing its proprietary mustard-based formulation against Panama Disease, a...

Tuesday, September 29, 2020, 12:36:37 PM

Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO...

Monday, December 21, 2020, 01:00:00 PM